Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies

Fosfomycin is being increasingly prescribed for multidrug-resistant bacterial infections. In patients with systemic involvement, intravenous fosfomycin is usually administered as a partner drug, as part of an antibiotic regimen. Hence, the knowledge of fosfomycin pharmacodynamic interactions (synerg...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonello, Roberta Maria, Principe, Luigi, Maraolo, Alberto Enrico, Viaggi, Valentina, Pol, Riccardo, Fabbiani, Massimiliano, Montagnani, Francesca, Lovecchio, Antonio, Luzzati, Roberto, Di Bella, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460049/
https://www.ncbi.nlm.nih.gov/pubmed/32785114
http://dx.doi.org/10.3390/antibiotics9080500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460049/
https://www.ncbi.nlm.nih.gov/pubmed/32785114
http://dx.doi.org/10.3390/antibiotics9080500

Ejemplares similares